News | April 15, 2014

Mevion Announces Partnership With Chiyoda Technol for Distribution of Proton Therapy Systems in Japan

April 15, 2014 — Mevion Medical Systems announced an agreement with Chiyoda Technol Corp. for the exclusive distribution of the Mevion S250 proton therapy system in the Japanese market. Chiyoda Technol is one of Japan’s leading providers of radiation supply, service and monitoring.

The Mevion S250 system is a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the high costs, prohibitive space requirements and cumbersome workflow that commonly define the treatment modality.

“The significantly reduced size and cost of the Mevion S250, paired with cutting-edge technology, is a perfect fit for the very progressive Japanese radiation therapy market,” said Kazuhiko Yamaguchi, president of Chiyoda Technol Corp. “We have a strong tradition of introducing state-of-the-art medical products and with the addition of the Mevion S250 proton therapy system, we are fulfilling the demand of our foremost customers and we expect to significantly increase the number of proton therapy centers in the next five years.”

“Mevion is proud to expand its partnership with Chiyoda Technol to provide this revolutionary proton therapy platform to clinicians and patients in Japan”, said Joseph K. Jachinowski, CEO of Mevion. “With Japan’s 20-year leadership in the clinical use of proton therapy, the Japanese market has always been a high priority and we are excited to see the very positive response the Mevion S250 is receiving from all proton experts.”

The Mevion S250 is installed at the Kling Proton Therapy Center at Barnes-Jewish Hospital at Washington University in St. Louis, benefiting pediatric patients and other cancer patients where proton therapy treatment is indicated. Five additional systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City; First Coast Oncology in Jacksonville, Fla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland.

For more information: www.mevion.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...